← Open Payments lookup

VICKI DEWEESE: Open Payments

NPI 1164411559 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,922 in 96 payments from 14 companies in 2025. Trend: 2023 $1,817 · 2024 $2,199 · 2025 $1,922

Food & beverage: $1,922
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.13$386
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)21$362
Supernus Pharmaceuticals, Inc.11$241
Otsuka America Pharmaceutical, Inc.12$199
ABBVIE INC.14$186
Teva Pharmaceuticals USA, Inc.5$129
Alkermes, Inc.4$93
Axsome Therapeutics, Inc.4$78
Lundbeck LLC2$56
Janssen Pharmaceuticals, Inc2$56

Products named: INGREZZA, CAPLYTA, Qelbree, VRAYLAR, REXULTI, ABILIFY ASIMTUFII, Auvelity, ARISTADA.

Industry payments across GA — which companies pay providers there.